Review



wild type egfr  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 97
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc wild type egfr
    Wild Type Egfr, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 708 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wild type egfr/product/Cell Signaling Technology Inc
    Average 97 stars, based on 708 article reviews
    wild type egfr - by Bioz Stars, 2026-02
    97/100 stars

    Images



    Similar Products

    antibodies human wild type egfr nsclc cell line h358  (ATCC)
    98
    ATCC antibodies human wild type egfr nsclc cell line h358
    Antibodies Human Wild Type Egfr Nsclc Cell Line H358, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies human wild type egfr nsclc cell line h358/product/ATCC
    Average 98 stars, based on 1 article reviews
    antibodies human wild type egfr nsclc cell line h358 - by Bioz Stars, 2026-02
    98/100 stars
    		  Buy from Supplier
    type egfr  (Carna Inc)
    95
    Carna Inc type egfr
    Type Egfr, supplied by Carna Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/type egfr/product/Carna Inc
    Average 95 stars, based on 1 article reviews
    type egfr - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    wild type, egfrflox/flox and fib-egfr ko mice  (Cyagen Biosciences)
    90
    Cyagen Biosciences wild type, egfrflox/flox and fib-egfr ko mice
    Wild Type, Egfrflox/Flox And Fib Egfr Ko Mice, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wild type, egfrflox/flox and fib-egfr ko mice/product/Cyagen Biosciences
    Average 90 stars, based on 1 article reviews
    wild type, egfrflox/flox and fib-egfr ko mice - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    wild-type egfr  (Thermo Fisher)
    90
    Thermo Fisher wild-type egfr
    Wild Type Egfr, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wild-type egfr/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    wild-type egfr - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    wild type egfr  (Cell Signaling Technology Inc)
    97
    Cell Signaling Technology Inc wild type egfr
    Wild Type Egfr, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/wild type egfr/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    wild type egfr - by Bioz Stars, 2026-02
    97/100 stars
    		  Buy from Supplier
    pbabe puro egfr wild-type  (Addgene inc)
    90
    Addgene inc pbabe puro egfr wild-type
    A, Diagram of domain architecture of <t>EGFR,</t> showing heterodimerization between EGFR and a binding partner such as Her2. Yellow star indicates approximate site of the common oncogenic L858 mutation, red star indicates approximate site of the N361 glycosylation site, green indicates ligands such as EGF or AREG that bind to EGFR to induce dimerization. B, Percentage of fluorescent cells from flow cytometry of MCF10A cells that were labeled with anti-EGFR antibody conjugated to Alexa-Fluor 488, or empty <t>puro-IRES-eGFP</t> vector as the stably fluorescent positive control which is not labeled by fluorescent antibody. Cells used were parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A. C, Representative immunofluorescent microscopy images of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A, stained for EGFR, vimentin, ATP1A1, or DAPI.
    Pbabe Puro Egfr Wild Type, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pbabe puro egfr wild-type/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    pbabe puro egfr wild-type - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    ba/f3 egfr wild-type cell line  (Crown Bioscience)
    90
    Crown Bioscience ba/f3 egfr wild-type cell line
    A, Diagram of domain architecture of <t>EGFR,</t> showing heterodimerization between EGFR and a binding partner such as Her2. Yellow star indicates approximate site of the common oncogenic L858 mutation, red star indicates approximate site of the N361 glycosylation site, green indicates ligands such as EGF or AREG that bind to EGFR to induce dimerization. B, Percentage of fluorescent cells from flow cytometry of MCF10A cells that were labeled with anti-EGFR antibody conjugated to Alexa-Fluor 488, or empty <t>puro-IRES-eGFP</t> vector as the stably fluorescent positive control which is not labeled by fluorescent antibody. Cells used were parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A. C, Representative immunofluorescent microscopy images of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A, stained for EGFR, vimentin, ATP1A1, or DAPI.
    Ba/F3 Egfr Wild Type Cell Line, supplied by Crown Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ba/f3 egfr wild-type cell line/product/Crown Bioscience
    Average 90 stars, based on 1 article reviews
    ba/f3 egfr wild-type cell line - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    ba/f3 egfr wild-type  (Crown Bioscience)
    90
    Crown Bioscience ba/f3 egfr wild-type
    A, Diagram of domain architecture of <t>EGFR,</t> showing heterodimerization between EGFR and a binding partner such as Her2. Yellow star indicates approximate site of the common oncogenic L858 mutation, red star indicates approximate site of the N361 glycosylation site, green indicates ligands such as EGF or AREG that bind to EGFR to induce dimerization. B, Percentage of fluorescent cells from flow cytometry of MCF10A cells that were labeled with anti-EGFR antibody conjugated to Alexa-Fluor 488, or empty <t>puro-IRES-eGFP</t> vector as the stably fluorescent positive control which is not labeled by fluorescent antibody. Cells used were parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A. C, Representative immunofluorescent microscopy images of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A, stained for EGFR, vimentin, ATP1A1, or DAPI.
    Ba/F3 Egfr Wild Type, supplied by Crown Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ba/f3 egfr wild-type/product/Crown Bioscience
    Average 90 stars, based on 1 article reviews
    ba/f3 egfr wild-type - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    kinase assay systems for both wild-type egfr and its mutants—t790m, l858r, and the dual l858r/t790m  (Promega)
    90
    Promega kinase assay systems for both wild-type egfr and its mutants—t790m, l858r, and the dual l858r/t790m
    A, Diagram of domain architecture of <t>EGFR,</t> showing heterodimerization between EGFR and a binding partner such as Her2. Yellow star indicates approximate site of the common oncogenic L858 mutation, red star indicates approximate site of the N361 glycosylation site, green indicates ligands such as EGF or AREG that bind to EGFR to induce dimerization. B, Percentage of fluorescent cells from flow cytometry of MCF10A cells that were labeled with anti-EGFR antibody conjugated to Alexa-Fluor 488, or empty <t>puro-IRES-eGFP</t> vector as the stably fluorescent positive control which is not labeled by fluorescent antibody. Cells used were parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A. C, Representative immunofluorescent microscopy images of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A, stained for EGFR, vimentin, ATP1A1, or DAPI.
    Kinase Assay Systems For Both Wild Type Egfr And Its Mutants—T790m, L858r, And The Dual L858r/T790m, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kinase assay systems for both wild-type egfr and its mutants—t790m, l858r, and the dual l858r/t790m/product/Promega
    Average 90 stars, based on 1 article reviews
    kinase assay systems for both wild-type egfr and its mutants—t790m, l858r, and the dual l858r/t790m - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    egfr wild-type p.l858r c.2573t > g  (Bio-Rad)
    90
    Bio-Rad egfr wild-type p.l858r c.2573t > g
    A, Diagram of domain architecture of <t>EGFR,</t> showing heterodimerization between EGFR and a binding partner such as Her2. Yellow star indicates approximate site of the common oncogenic L858 mutation, red star indicates approximate site of the N361 glycosylation site, green indicates ligands such as EGF or AREG that bind to EGFR to induce dimerization. B, Percentage of fluorescent cells from flow cytometry of MCF10A cells that were labeled with anti-EGFR antibody conjugated to Alexa-Fluor 488, or empty <t>puro-IRES-eGFP</t> vector as the stably fluorescent positive control which is not labeled by fluorescent antibody. Cells used were parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A. C, Representative immunofluorescent microscopy images of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A, stained for EGFR, vimentin, ATP1A1, or DAPI.
    Egfr Wild Type P.L858r C.2573t > G, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/egfr wild-type p.l858r c.2573t > g/product/Bio-Rad
    Average 90 stars, based on 1 article reviews
    egfr wild-type p.l858r c.2573t > g - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    A, Diagram of domain architecture of EGFR, showing heterodimerization between EGFR and a binding partner such as Her2. Yellow star indicates approximate site of the common oncogenic L858 mutation, red star indicates approximate site of the N361 glycosylation site, green indicates ligands such as EGF or AREG that bind to EGFR to induce dimerization. B, Percentage of fluorescent cells from flow cytometry of MCF10A cells that were labeled with anti-EGFR antibody conjugated to Alexa-Fluor 488, or empty puro-IRES-eGFP vector as the stably fluorescent positive control which is not labeled by fluorescent antibody. Cells used were parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A. C, Representative immunofluorescent microscopy images of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A, stained for EGFR, vimentin, ATP1A1, or DAPI.

    Journal: bioRxiv

    Article Title: Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function

    doi: 10.1101/2024.07.12.603279

    Figure Lengend Snippet: A, Diagram of domain architecture of EGFR, showing heterodimerization between EGFR and a binding partner such as Her2. Yellow star indicates approximate site of the common oncogenic L858 mutation, red star indicates approximate site of the N361 glycosylation site, green indicates ligands such as EGF or AREG that bind to EGFR to induce dimerization. B, Percentage of fluorescent cells from flow cytometry of MCF10A cells that were labeled with anti-EGFR antibody conjugated to Alexa-Fluor 488, or empty puro-IRES-eGFP vector as the stably fluorescent positive control which is not labeled by fluorescent antibody. Cells used were parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A. C, Representative immunofluorescent microscopy images of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR wild-type (WT) or EGFR N361A, stained for EGFR, vimentin, ATP1A1, or DAPI.

    Article Snippet: Introduction of N361A by site-directed mutagenesis on the pBABE puro EGFR wild-type (EGFR WT, RRID:Addgene_11011) and pBABE puro EGFR L858R (RRID:Addgene_11012) plasmids was performed by Azenta. pBABE puro IRES-eGFP (RRID:Addgene_14430).

    Techniques: Binding Assay, Mutagenesis, Glycoproteomics, Flow Cytometry, Labeling, Plasmid Preparation, Stable Transfection, Positive Control, Microscopy, Staining

    A, Time course of relative viability of in parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR WT or EGFR N361A, measured by Cell-Titer Glo luciferase assay (CTG) in stimulated media with 20 ng/mL of EGF. B, Dose course of relative viability of MCF10A cells overexpressing the indicated constructs after stimulation by EGF for 72 hours, measured by CTG. C, Dose course of relative viability of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR WT or EGFR N361A upon stimulation by AREG for 72 hours, both measured by CTG; ns = not significant, * p < 0.05; *** p < 0.001, n = 3; D, Immunoblots of whole cell lysates of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR WT or EGFR N361A stimulated with an additional 20 ng/mL of EGF for 15 minutes.

    Journal: bioRxiv

    Article Title: Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function

    doi: 10.1101/2024.07.12.603279

    Figure Lengend Snippet: A, Time course of relative viability of in parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR WT or EGFR N361A, measured by Cell-Titer Glo luciferase assay (CTG) in stimulated media with 20 ng/mL of EGF. B, Dose course of relative viability of MCF10A cells overexpressing the indicated constructs after stimulation by EGF for 72 hours, measured by CTG. C, Dose course of relative viability of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR WT or EGFR N361A upon stimulation by AREG for 72 hours, both measured by CTG; ns = not significant, * p < 0.05; *** p < 0.001, n = 3; D, Immunoblots of whole cell lysates of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR WT or EGFR N361A stimulated with an additional 20 ng/mL of EGF for 15 minutes.

    Article Snippet: Introduction of N361A by site-directed mutagenesis on the pBABE puro EGFR wild-type (EGFR WT, RRID:Addgene_11011) and pBABE puro EGFR L858R (RRID:Addgene_11012) plasmids was performed by Azenta. pBABE puro IRES-eGFP (RRID:Addgene_14430).

    Techniques: Luciferase, Construct, Western Blot

    A, Immunofluorescent images of MCF10A cells from in situ proximity ligation assays using primary antibodies against EGFR and HER2 to assess co-localization. Cells are parental or overexpress exogenous cDNAs of EGFR WT, EGFR N361A, EGFR L858R, or a single construct containing two mutations EGFR N361A/L858R. Scale bar represents 50 μm. B, Representative quantification of mean pixel intensity of cellular regions defined by rhodamine Actin stain, including five replicate images per condition. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001, n = 5.

    Journal: bioRxiv

    Article Title: Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function

    doi: 10.1101/2024.07.12.603279

    Figure Lengend Snippet: A, Immunofluorescent images of MCF10A cells from in situ proximity ligation assays using primary antibodies against EGFR and HER2 to assess co-localization. Cells are parental or overexpress exogenous cDNAs of EGFR WT, EGFR N361A, EGFR L858R, or a single construct containing two mutations EGFR N361A/L858R. Scale bar represents 50 μm. B, Representative quantification of mean pixel intensity of cellular regions defined by rhodamine Actin stain, including five replicate images per condition. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001, n = 5.

    Article Snippet: Introduction of N361A by site-directed mutagenesis on the pBABE puro EGFR wild-type (EGFR WT, RRID:Addgene_11011) and pBABE puro EGFR L858R (RRID:Addgene_11012) plasmids was performed by Azenta. pBABE puro IRES-eGFP (RRID:Addgene_14430).

    Techniques: In Situ, Ligation, Construct, Staining

    A-B, Dose course of relative viability measured by CTG of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR WT or EGFR N361A after 72 hours of treatment with either (A) necitumumab or (B) osimertinib. ns = not significant, * p < 0.05; *** p < 0.001, n = 3.

    Journal: bioRxiv

    Article Title: Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function

    doi: 10.1101/2024.07.12.603279

    Figure Lengend Snippet: A-B, Dose course of relative viability measured by CTG of parental MCF10A cells or MCF10A cells overexpressing cDNAs of EGFR WT or EGFR N361A after 72 hours of treatment with either (A) necitumumab or (B) osimertinib. ns = not significant, * p < 0.05; *** p < 0.001, n = 3.

    Article Snippet: Introduction of N361A by site-directed mutagenesis on the pBABE puro EGFR wild-type (EGFR WT, RRID:Addgene_11011) and pBABE puro EGFR L858R (RRID:Addgene_11012) plasmids was performed by Azenta. pBABE puro IRES-eGFP (RRID:Addgene_14430).

    Techniques: